PATENT CLAIM ANALYSIS

Application Number: 16289494
Application Type: Utility
Filing Date: 2019-02
Publication Date: 2019-06
Patent Classification: ["424", "085200"]

Abstract:
Provided herein are pharmaceutical compositions comprising tumoricidal and/or antimicrobial components isolated from the supernatant of NK-92 cell medium and methods of using the compositions for killing cancer cells.

Claim (Index 45):
The composition of  claim 37 , wherein the NK-92 cells comprise modified NK-92 cells.

Metadata:
- Claim Count in Document: 59.0
- Percentile: 99.0
- Lexical Diversity: 1.11538
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15032518', '16212578', '14634607', '12282152', '15501068']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7451807018626124
- 35 USC 102 Novelty (BERT): 0.5603589394738666
- Combined Prediction Score: 0.7266985256237378
- Mean Citation Score: 292.825
- Max Citation Score: 434.64212
- Similarity Product: 355.3516149083161

Labels:
- Claim Label 101: 0
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test